Exponent, Inc. (EXPO) is a publicly traded company in the Industrials — Engineering & Construction industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health.
Is Exponent, Inc. stock overvalued or undervalued in 2026?
Exponent, Inc. (EXPO) trades at 34.6× earnings (P/E), above the median of the 297 industrials companies over $2bn in Kaplio's universe. At the decade median (46.9×) $109 (+36 %); at its sector median (25.8×) $60 (-25 %).
Kaplio overview: Exponent, Inc.
Market cap $4B · 52 weeks $54 – $80 (0 % below the high) · P/E 34.6× · 2027 expected P/E 34.8× · Dividend 1.6 % · 11 years rising · Closing price, Oct 30 · accounts published Oct 29.
- Valuation: P/E 34.6× (fairly priced).
- Business: ROIC 31 % (excellent).
- Balance sheet: Net cash/EBITDA 0.9× (solid).
- Earnings: 8 of 8 (on track).
What would it be worth at its usual multiples?
At the decade median (46.9×) $109 (+36 %); at its sector median (25.8×) $60 (-25 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in industrials: 9 of 10 pass
- Capex / Revenue 1.6 %, fails.
- 5y revenue growth 8.4 %, passes.
- Operating margin 20.6 %, passes.
- ROIC 30.9 %, passes.
- FCF conversion 115.4 %, passes.
- Net debt / EBITDA −0.9×, passes.
- Altman Z-Score 7.9, passes.
- Piotroski F-Score 5 de 9, passes.
- P/E vs own 10y history 34.6×, passes.
- Cycle-adjusted EV/EBITDA 23.9×, passes.
Against its peers (reference peers) — Exponent, Inc.: P/E 34.6×; EV/EBITDA 23.9×; ROIC 30.9 %; $3.8B. MYR Group Inc. (P/E 23.0×; EV/EBITDA 13.6×; ROIC 15.6 %; $4.4B), KBR, Inc. (P/E 11.1×; EV/EBITDA 8.3×; ROIC 10.2 %; $4.9B), Legence Corp. Class A Common stock (P/E —; EV/EBITDA 31.6×; ROIC 4.4 %; $5.4B).
Expensive or cheap against its last ten years?
P/E at each close: today 34.6× · median 46.9× · minimum 23.2× · maximum 79.4× · cheap below 40.8× · expensive above 57.3×. It has been cheaper than today only 16% of the time over its last ten years.
Dividend
solid · Yield 1.6 % ($1.21 per share in 2025) · Years raising it ≥ 11 · 5-year growth +10 % a year · Free cash flow coverage 2.1× · With $1,000 invested today you'd collect $15.70 a year ($1.31 a month).
Profitability
| Return on Equity | 34.61% |
| Return on Invested Capital | 30.95% |
| Return on Assets | 22.93% |
| Gross Margin | 24.49% |
| Operating Margin | 28.93% |
| Net Margin | 23.63% |
Financial Health
| Debt / Equity | 0.26 |
| Current Ratio | 1.94 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 7.86 |
Price Performance
| 1 month | +19.26% |
| 3 months | +17.56% |
| Year-to-date | +15.55% |
| 1 year | +13.35% |
| 3 years | +8.59% |
| 5 years | -29.89% |
| 10 years | +181.12% |
Dividend History
Paid in the last 12 months: $1.2300 per share in 4 payments.
| Date | Amount |
|---|---|
| 2026-09-04 | $0.3100 |
| 2026-06-05 | $0.3100 |
| 2026-03-06 | $0.3100 |
| 2025-12-05 | $0.3000 |
| 2025-09-05 | $0.3000 |
| 2025-06-06 | $0.3000 |
| 2025-03-07 | $0.3000 |
| 2024-12-06 | $0.2800 |
| 2024-09-06 | $0.2800 |
| 2024-06-07 | $0.2800 |
Amounts adjusted for stock splits.
Related companies: TTEK · LGN · MYRG · HURN · FLR · FCN · KBR
Explore sector: Industrials · Engineering & Construction
More sections of EXPO: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks